Navigation Links
Delcath Reports 2014 Second Quarter Results
Date:8/6/2014

NEW YORK, Aug. 6, 2014 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) today reported financial results and operational developments for the fiscal second quarter ended June 30, 2014. Developments for the quarter and recent weeks subsequent to quarter end are as follows:

  • Adoption of CHEMOSAT in Europe continued with 50 treatments performed in the first seven months of 2014, as compared to 22 treatments in the same period of 2013
  • Since initiation of European commercialization, 123 treatments performed on 83 patients as of July 31, 2014
  • Delcath-sponsored Phase 2 study in primary liver cancer (hepatocellular carcinoma or HCC) opened for enrollment at first center in Germany; Johan Wolfgang Goethe University Hospital in Frankfurt
  • Two investigator-initiated clinical trials initiated; Leiden University Medical Center, Leiden, Netherlands enrolls and treats first patient in study of CHEMOSAT to treat liver metastasis in colorectal cancer; Johan Wolfgang Goethe University Hospital in Frankfurt trial open for patient enrollment to study use of CHEMOSAT to treat HCC
  • Second quarter 2014 quarterly net cash utilization of $4.0 million; Company lowers average cash utilization guidance for the remainder of 2014 to $4 to $5 million a quarter; Cash as of June 30, 2014 was $27.3 million
  • "We continue to see steady clinical adoption of CHEMOSAT in Europe," commented Jennifer K. Simpson, Interim Co-President & Co-CEO.  "As of July 31st of this year, a total of 50 treatments, of which 22 were retreatments, were performed at leading European cancer centers.  This compares with 22 treatments and six retreatments during the first seven months of 2013.  We believe the growth in performed treatments reflects expanded European clinical experience with CHEMOSAT.  Our company-sponsored clinical program for HCC is also mov
    '/>"/>

    SOURCE Delcath Systems, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Delcath Systems, Inc. Secures $20 Million Credit Facility
    2. Delcath Highlights First Quarter 2012 And Recent Accomplishments
    3. Delcath to Webcast Managements Presentation at Annual Meeting of Stockholders
    4. Delcath Prices $20 Million Public Offering of Common Stock and Warrants
    5. Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program
    6. Delcath Announced Changes To Board Of Directors
    7. Delcath To Present At JMP Securities Healthcare Conference On July 12
    8. Delcath To Conduct Second Quarter 2012 Results Conference Call
    9. Delcath Reports Second Quarter 2012 Financial Results And Highlights Recent Accomplishments
    10. Delcath To Present At Upcoming Investor Conferences
    11. Delcath Submits New Drug Application For Proprietary Chemosaturation System To The U.S. Food And Drug Administration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... 19, 2014  CytRx Corporation (Nasdaq: CYTR ... oncology, today announced that David J. Haen , ... NewsMakers in the Biotech Industry Conference on Friday, September 26 ... will take place at the Millennium Broadway Hotel in ... A live and archived webcast of the presentation will ...
    (Date:9/19/2014)... 19, 2014 Reductions in kidney ... years in people with diabetes type 2 ... benefits for the kidneys." Australian researchers have ... 2 diabetes leads to persistent reductions in kidney failure ... The global study has found that, five and a ...
    (Date:9/18/2014)... ... announced the addition of the "Global ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... chromosomes using molecular biology to understand the ... It plays a crucial role in the ...
    Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
    ... TRIANGLE PARK, N.C. , June 2 ... it has received a letter from the U.S. Food ... its respiratory products Serevent® and Advair®.  The letter concludes ... committee meetings regarding the safety profile of long-acting beta2-agonists ...
    ... June 2 The Georgia Advanced Surgery ... first fully accredited surgical center for performing all ... true outpatient setting – has officially opened. ... highly advanced, minimally invasive surgical techniques that spare ...
    Cached Medicine Technology:GSK Announces Revised Product Labels for Serevent® and Advair® 2New Georgia Advanced Surgery Center Provides Women Many Unique Benefits 2
    (Date:9/20/2014)... Final Cut Pro X Plugin developers ... Information theme for FCPX filmmakers. , “Fun, cool, and simple ... theme,” says Christina Austin, CEO of Pixel Film Studios. “It ... Information features easy to use controls that give the user ... the background color, color of each circle outline, the position ...
    (Date:9/20/2014)... 20, 2014 The children of Branches ... and active play they need. An empty lot at ... Lakeview Campus was transformed into a kid-designed playspace in ... volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney (@CitizenDisney), area ... believes a playground is more than a playground. It’s ...
    (Date:9/19/2014)... Kansas City, KS (PRWEB) September 19, 2014 ... City, is responding to families in regions of the Philippines ... volcano. , More than 1,060 families evacuated to the ... tropical storm Fung-Wong brought heavy rain and gusty winds to ... Metro-Manila Friday causing heavy flooding. Some homes filled with more ...
    (Date:9/19/2014)... (PRWEB) September 19, 2014 Hastings and Hastings, ... years in the industry, announces a record number of visitors ... a wide variety of serious injury cases as well as ... with dog bite related accident cases and others. Having served ... Hastings has stood the test of time when it comes ...
    (Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- U.S. military troops ... of skin cancer, according to a new study. ... abroad, researchers revealed. In some cases, military personnel developed ... the color, shape or size of their moles since ... be risk factors for skin cancer, the study authors ...
    Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Some U.S. Troops May Face Greater Skin Cancer Risk 2
    ... blood pressure causes inactivation of nitric oxide, a hormone ... If high blood pressure is left untreated, it does ... spiral out of control. According to the researchers at ... rats and found that nitric oxide, which helps control ...
    ... men suffering from eating disorders. Men who suffer from ... with the same problems, researchers say.// ,Eating ... which become dangerously thin and brittle. This is linked ... particularly calcium.Low bone mineral density (BMD) can lead to ...
    ... patients who drink in moderation – between one and ... strokes than either abstainers or heavier drinkers who consume ... researchers. ,Dr Kenneth Mukamal and colleagues at Beth ... alcohol consumption among elderly patients appeared to protect against ...
    ... is not as accurate as first thought, says research. ,Their ... system worked reasonably well for children whose parents were of ... was "misleading".// ,In fact, children of very tall ... worked out for them, and children of extremely short parents ...
    ... who suffer from constipation are nearly three times more likely ... Robert Frank, Professor of Biostatistics and Statistics at the University ... Parkinson's was noted almost 2 centuries back from a clinical ... one bowel movement per day. This study is part of ...
    ... have identified a growth factor that triggers blood ... Dr. Jennifer of Genentech Inc. and colleagues reported ... factor, or EG-VEGF. The finding could lead the ... The endocrine glands produce various hormones such as ...
    Cached Medicine News:
    ... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
    Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
    ... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
    ... With advanced glass technologies and designs, ... high magnification views of the posterior ... provide image quality previously unattainable with ... for more detailed and comprehensive views, ...
    Medicine Products: